Archives: Speakers

Marianne Heksem

Marianne has a master of food science and has worked in the dairy industry 16 years and for the last 11  years with NPD in Kavli.

Glen Foster

The seventh Xero employee in the UK, Glen has over 15 years’ experience in the accounting technology industry. As Director of Accounting Partners at Xero, his role is to develop and execute strategies that enable our accounting partner channel to flourish.

Glen is passionate about the role technology plays in moving the accounting industry forward as well as the impact it has on small business. He’s focused on providing solutions for accounting firms to streamline their day-to-day processes This enables them to shift the relationship from being purely compliance-led to delivering additional value and maximising the benefits of cloud technology.

Kent Thoelke

As PRA’s Chief Scientific Officer, Mr Thoelke provides corporate oversight and strategy for Scientific & Medical Affairs, Pharmacovigilance & Patient Safety, Therapeutic Centers of Excellence, Real World Data, Patient Access & Experience, Digital Health & Virtual Trials, and their integration into operational delivery. Mr Thoelke is an industry pioneer in the application of mobile first strategies, which integrate clinical trials and provide access directly to patients in both virtual and hybrid-virtual models. He emphasizes leveraging real world data, social insights, and patient connectivity to advance global drug development.

Mimi Choon-Quinones

I am passionate about advocating for patients by improving healthcare policies, advancing medical knowledge, driving innovative digital solutions in the quest to increase medical access to treatments for patients. I feel it is one of my responsibilities to support every patient around the world who struggles to get access to medicines.

Dr Mira Doig

Mira Doig, Ph.D., Technical Director at ABS Laboratories, Ltd.
Mira has over 30 years of experience performing regulated bioanalysis of drugs, metabolites, and biomarkers using GC-MS & LC-MS/MS, and has supported multiple drug development programs from discovery to MAA/NDA submission. In 1997 she established ABS Laboratories as a GLP/GCP accredited bioanalytical contract research organization, which was acquired by ACM Global Labs in 2018. Today, she continues to oversee ACM’s bioanalysis laboratory services and maintains technical and operational excellence.